It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth

被引:6
作者
Oberle, Megan M. [1 ,2 ]
Kelly, Aaron S. [1 ,2 ]
机构
[1] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Sch Med, Ctr Pediat Obes Med, Minneapolis, MN 55455 USA
关键词
GLP-1 receptor agonists; pedatrics; type; 2; diabetes; obesity; weight management; adolescents; DOUBLE-BLIND; WEIGHT-LOSS; LIRAGLUTIDE; PLACEBO; SAFETY; PHARMACOKINETICS; MANAGEMENT; MELLITUS; THERAPY; OBESITY;
D O I
10.3389/fendo.2019.00738
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页数:3
相关论文
共 33 条
[1]   A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients [J].
Abd El Aziz, Mirna S. ;
Kahle, Melanie ;
Meier, Juris J. ;
Nauck, Michael A. .
DIABETES OBESITY & METABOLISM, 2017, 19 (02) :216-227
[2]  
Administration UDOFaD, 2018, FDA APPR NEW TREAT P
[3]   Efficacy and safety of incretin therapy in type 2 diabetes - Systematic review and meta-analysis [J].
Amori, Renee E. ;
Lau, Joseph ;
Pittas, Anastassios G. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (02) :194-206
[4]   Evaluation and Management of Youth-Onset Type 2 Diabetes: A Position Statement by the American Diabetes Association [J].
Arslanian, Silva ;
Bacha, Fida ;
Grey, Margaret ;
Marcus, Marsha D. ;
White, Neil H. ;
Zeitler, Philip .
DIABETES CARE, 2018, 41 (12) :2648-2668
[5]   Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis [J].
Bethel, M. Angelyn ;
Patel, Rishi A. ;
Merrill, Peter ;
Lokhnygina, Yuliya ;
Buse, John B. ;
Mentz, Robert J. ;
Pagidipati, Neha J. ;
Chan, Juliana C. ;
Gustavson, Stephanie M. ;
Iqbal, Nayyar ;
Maggioni, Aldo P. ;
Ohman, Peter ;
Poulter, Neil R. ;
Ramachandran, Ambady ;
Zinman, Bernard ;
Hernandez, Adrian F. ;
Holman, Rury R. .
LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (02) :105-113
[6]   Management of Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) in Children and Adolescents [J].
Copeland, Kenneth C. ;
Silverstein, Janet ;
Moore, Kelly R. ;
Prazar, Greg E. ;
Raymer, Terry ;
Shiffman, Richard N. ;
Springer, Shelley C. ;
Thaker, Vidhu V. ;
Anderson, Meaghan ;
Spann, Stephen J. ;
Flinn, Susan K. .
PEDIATRICS, 2013, 131 (02) :364-382
[7]   Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12-17 Years [J].
Danne, Thomas ;
Biester, Torben ;
Kapitzke, Kerstin ;
Jacobsen, Sanja H. ;
Jacobsen, Lisbeth V. ;
Petri, Kristin C. Carlsson ;
Hale, Paula M. ;
Kordonouri, Olga .
JOURNAL OF PEDIATRICS, 2017, 181 :146-+
[8]  
Davies MJ, 2018, DIABETES CARE, V41, P2669, DOI [10.2337/dci18-0033, 10.1007/s00125-018-4729-5]
[9]   Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials [J].
Dicembrini, Ilaria ;
Nreu, Besmir ;
Scatena, Alessia ;
Andreozzi, Francesco ;
Sesti, Giorgio ;
Mannucci, Edoardo ;
Monami, Matteo .
ACTA DIABETOLOGICA, 2017, 54 (10) :933-941
[10]  
Filippatos Theodosios D, 2014, Rev Diabet Stud, V11, P202, DOI 10.1900/RDS.2014.11.202